Cereno Scientific AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arterial Hypertension
- Conditions
- Pulmonary Arterial Hypertension
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Cereno Scientific AB
- Registration Number
- NCT06321705
- Locations
- 🇸🇪
Fredrik Frick, Gothenburg, Sweden
Effect of CS1 in Subjects With Pulmonary Arterial Hypertension
Phase 2
Completed
- Conditions
- Pulmonary Arterial Hypertension
- Interventions
- Drug: CS1 Administration
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Cereno Scientific AB
- Target Recruit Count
- 25
- Registration Number
- NCT05224531
- Locations
- 🇸🇪
Fredrik Frick, Gothenburg, Sweden
Study Investigation Pharmacokinetics and Pharmacodynamics of CS1
- First Posted Date
- 2019-04-04
- Last Posted Date
- 2019-04-08
- Lead Sponsor
- Cereno Scientific AB
- Target Recruit Count
- 30
- Registration Number
- NCT03903302
- Locations
- 🇸🇪
CTC Clinical Trial Consultants AB, Uppsala, Sweden
© Copyright 2025. All Rights Reserved by MedPath